This observation suggests that differential gene expression may create conditions conducive to VC development (i.e., an increase in ALPL expression alongside a reduction in TREM2 expression), potentially explaining some of the regional differences in VC, brain perfusion, and neurovascular pathology observed in AD. The gene discussed is TREM2; the disease is Alzheimer disease.